- Product Details
Keywords
- Lopinavir
- Lopinavir powder
- CAS 192725-17-0
Quick Details
- ProName: API-Lopinavir, High purity Lopinavir
- CasNo: 192725-17-0
- Molecular Formula: C37H48N4O5
- Appearance: white powder
- Application: Used in medicine, health products, foo...
- DeliveryTime: immediately
- PackAge: aluminum foil bag
- Port: HK, Shanghai, Shenzhen
- ProductionCapacity: 100 Kilogram/Month
- Purity: 99%
- Storage: cool and dry place
- Transportation: email: wonda-chem@outlook.com
- LimitNum: 10 Gram
Superiority
1.high quality:
quality is life. quality is the most important element for all goods. we have a lab doing research in wuhan china. hplc and nmr is available if needed.
2.reasonable price:
we provide high quality products with competitive price in china. all customers are welcomed to send us inquiries and get quotation.
3.low moq:
no worry about the low moq, our moq is 1 gram or even lower.
4.good service.
fast response. we promise to reply within 24 hours including holidays and send quotation sheet and other documents within 48 hours.
5. fast shipping and secure courier.
we promise to send out products and provide tracking number within 3 working days. and we send via different couriers based on different destination countries. we usually use nl post, hk post, germany post, eub, etk, etc.
Details
Items |
Specifications |
Results |
Characters |
A white or almost white crystalline powder |
Conforms |
Identification(1H-NMR |
Conforms to the structure |
Conforms |
LOD(%w/w) |
NMT0.5% |
0.18% |
Residue on ignition |
NMT0.1% |
0.06% |
Heavy metals (%w/w) |
NMT20ppm |
Conforms |
Purity (HPLC ,%a/a) |
NLT99.0% |
99.7% |
Residual solvents |
Methanol NMT3000ppm |
Conforms |
Dichloromethane NMT3000ppm |
Conforms |
|
Ethanol NMT3000ppm |
Conforms |
|
Ethyl acetate NMT3000ppm |
Conforms |
|
n-Heptane NMT3000ppm |
Conforms |
|
Conclusion : meets specifications |
Lopinavir is an antiretroviral of the protease inhibitor class. Inhibition of HIV-1 protease prevents cleavage of the viral polyprotein
precursor and results in the release of immature, noninfectious virions. A component of combination therapy to treat HIV/AIDS.